Skip to content

Nucleconsult

Active Private limited companyfounded 2012active for 14 yearsKapelleke 3, 3202 AarschotKBO/BCE: BE 0843.218.228

Lifetime

14 annual accounts with figures on one time axis
peak of €315,193 in 2024
€275,182▼ 12.7%
peak of €219,727 in 2024
€194,820▼ 11.3%
peak of €773,934 in 2025
€773,934▲ 22.5%
€57,839▼ 24.7%
Board2 names since 2018
2 directors and 1 other
Documentsfilings and deeds
05-05-202687 days before the deadline
2025micro format
Gross margin from €315,193 to €275,182Company renamed from Dr.R.VERSCUREN,nucleairegeneeskunde to N… 30-12Dividend €52,761Equity from €631,875 to €773,934Debts from €76,775 to €57,839Investments €12,450

Key points

from the 2025 annual accounts

Equity

€773,934 ▲ 22.5%

Nucleconsult has made a profit in every financial year since 2012.

Turnover

≈ €550,000 estimated

The micro format states no turnover.

Investments

€12,450 5.8 times depreciation
202120222025

Green is investment, beige is depreciation.

Liquidity

14.17 was 9.20 in 2024

Short-term debts fell from €76,775 to €57,839.

Filings

14 annual accounts since 2012
AprilJune31 JulyOctober201520202025

The last five annual accounts were filed 48 to 92 days before the end of the period.

Board

2 joined

New directors. Latest change 30-12-2025 · 2 in office.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,815 companies had the same profile as Nucleconsult has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,912 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,815 companies, not a prediction for Nucleconsult. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
Board & ownership

Recent changes

Company renamed from Dr.R.VERSCUREN,nucleairegeneeskunde to Nucleconsult (director) and (director) change roles · “Devennootschapheefttotvoorwerpdeuitoefeningvandegeneeskundedoordedeartsen-aandeelhouders,metspecialisatienucle…” (deed in Dutch) · General meeting of 12-12-2025 · Gazette deed
appointed as manager General meeting of 28-05-2018 · Gazette deed
Incorporation published on 13-02-2012 · Gazette deed
2 establishments registered Tienen and Aarschot
All 26 events

Official details

Source: KBO
Status
Active since 23-01-2012Normal situation
Activity
“Het verlenen van advies;” (deed in Dutch)From the articles, 7 activities1 activities on the establishment units
Establishment units
2.207.930.7273300 Tienen, since 23-01-2012
2.207.931.1233200 Aarschot, since 23-01-2012
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

€831,773▲ 17.4%
Filing
Filed on 05-05-2026, 87 days before the end of the filing period
Financials

Insights on Nucleconsult

Nucleconsult files the micro format. That format states no turnover. The gross margin rose from €123,587 in 2012 to €275,182 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Nucleconsult

What is the company number of Nucleconsult?
The company number of Nucleconsult is 0843.218.228. The VAT number is the same number with BE in front: BE 0843.218.228.
Where is Nucleconsult based?
The registered office is at Kapelleke 3, 3202 Aarschot.Company details
What is the legal form of Nucleconsult?
Nucleconsult is a private limited company (BV).
When was Nucleconsult founded?
Nucleconsult was founded on 23-01-2012.
Is Nucleconsult still active?
Yes, Nucleconsult is an active enterprise in the KBO register.
What is the turnover of Nucleconsult?
The turnover in financial year 2025 is ≈ €550,000. This figure is estimated from the gross margin of €275,182 and 1,019 comparable companies of the same size. It probably lies between €380,000 and €810,000. It is a rough estimate.Financials
Is Nucleconsult profitable?
In financial year 2025, Nucleconsult made a profit of €194,820.
Where can I find the annual accounts of Nucleconsult?
Nucleconsult filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Nucleconsult due?
Nucleconsult must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.